BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 24273218)

  • 1. Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women.
    Liu ZM; Ho SC; Chen YM; Ho S; To K; Tomlinson B; Woo J
    Mol Nutr Food Res; 2014 Apr; 58(4):709-17. PubMed ID: 24273218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.
    Liu ZM; Ho SC; Woo J; Chen YM; Wong C
    Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of whole soy and purified daidzein on ambulatory blood pressure and endothelial function--a 6-month double-blind, randomized controlled trial among Chinese postmenopausal women with prehypertension.
    Liu ZM; Ho SC; Chen YM; Tomlinson B; Ho S; To K; Woo J
    Eur J Clin Nutr; 2015 Oct; 69(10):1161-8. PubMed ID: 25782428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of whole soy and purified isoflavone daidzein on renal function--a 6-month randomized controlled trial in equol-producing postmenopausal women with prehypertension.
    Liu ZM; Ho SC; Chen YM; Tang N; Woo J
    Clin Biochem; 2014 Sep; 47(13-14):1250-6. PubMed ID: 24877660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of whole soy and purified daidzein on androgenic hormones in chinese equol-producing post-menopausal women: a six-month randomised, double-blinded and Placebo-Controlled trial.
    Liu ZM; Li G; Zhang D; Ho SC; Chen YM; Ma J; Huang Q; Li S; Ling WH
    Int J Food Sci Nutr; 2020 Aug; 71(5):644-652. PubMed ID: 31914834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 6-month effect of whole soy and purified isoflavones daidzein on thyroid function-A double-blind, randomized, placebo controlled trial among Chinese equol-producing postmenopausal women.
    Liu ZM; Zhang D; Li G; Ho SC; Chen YM; Ma J; Huang Q; Li S; Ling WH
    Phytother Res; 2021 Oct; 35(10):5838-5846. PubMed ID: 34494323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A six-month randomized controlled trial of whole soy and isoflavones daidzein on body composition in equol-producing postmenopausal women with prehypertension.
    Liu ZM; Ho SC; Chen YM; Woo J
    J Obes; 2013; 2013():359763. PubMed ID: 23984051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of whole soy and isoflavones daidzein on bone turnover and inflammatory markers: a 6-month double-blind, randomized controlled trial in Chinese postmenopausal women who are equol producers.
    Liu ZM; Chen B; Li S; Li G; Zhang D; Ho SC; Chen YM; Ma J; Qi H; Ling WH
    Ther Adv Endocrinol Metab; 2020; 11():2042018820920555. PubMed ID: 32595918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial.
    Mangano KM; Hutchins-Wiese HL; Kenny AM; Walsh SJ; Abourizk RH; Bruno RS; Lipcius R; Fall P; Kleppinger A; Kenyon-Pesce L; Prestwood KM; Kerstetter JE
    Nutr Res; 2013 Dec; 33(12):1026-33. PubMed ID: 24267042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research protocol: effect of natural S-equol on blood pressure and vascular function--a six-month randomized controlled trial among equol non-producers of postmenopausal women with prehypertension or untreated stage 1 hypertension.
    Liu ZM; Ho SC; Chen YM; Xie YJ; Huang ZG; Ling WH
    BMC Complement Altern Med; 2016 Mar; 16():89. PubMed ID: 26928904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risks in relation to daidzein metabolizing phenotypes among Chinese postmenopausal women.
    Liu ZM; Ho SC; Chen YM; Liu J; Woo J
    PLoS One; 2014; 9(2):e87861. PubMed ID: 24533060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production.
    Hall WL; Vafeiadou K; Hallund J; Bügel S; Koebnick C; Reimann M; Ferrari M; Branca F; Talbot D; Dadd T; Nilsson M; Dahlman-Wright K; Gustafsson JA; Minihane AM; Williams CM
    Am J Clin Nutr; 2005 Dec; 82(6):1260-8; quiz 1365-6. PubMed ID: 16332659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equol production capability is associated with favorable vascular function in postmenopausal women using tibolone; no effect with soy supplementation.
    Törmälä R; Appt S; Clarkson TB; Groop PH; Rönnback M; Ylikorkala O; Mikkola TS
    Atherosclerosis; 2008 May; 198(1):174-8. PubMed ID: 17961576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.
    Tousen Y; Uehara M; Abe F; Kimira Y; Ishimi Y
    Nutr J; 2013 Sep; 12():127. PubMed ID: 24034304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
    Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
    Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: lack of effect of soy supplementation.
    Törmälä RM; Appt S; Clarkson TB; Tikkanen MJ; Ylikorkala O; Mikkola TS
    Climacteric; 2007 Dec; 10(6):471-9. PubMed ID: 18049940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
    Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
    Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of soy isoflavone supplementation on endothelial dysfunction and oxidative stress in equol-producing postmenopausal women.
    Pusparini ; Yenny ; Hidayat A
    Endocr Metab Immune Disord Drug Targets; 2015; 15(1):71-9. PubMed ID: 25441486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soya isoflavone consumption in relation to carotid intima-media thickness in Chinese equol excretors aged 40-65 years.
    Cai Y; Guo K; Chen C; Wang P; Zhang B; Zhou Q; Mei F; Su Y
    Br J Nutr; 2012 Nov; 108(9):1698-704. PubMed ID: 22373572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoflavone supplement composition and equol producer status affect gene expression in adipose tissue: a double-blind, randomized, placebo-controlled crossover trial in postmenopausal women.
    van der Velpen V; Geelen A; Hollman PC; Schouten EG; van 't Veer P; Afman LA
    Am J Clin Nutr; 2014 Nov; 100(5):1269-77. PubMed ID: 25332325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.